| # | Drug | Count |
|---|---|---|
| 0 | SITAGLIPTIN | 146 |
| 1 | EXENATIDE | 39 |
| 2 | PANCRELIPASE | 38 |
| 3 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 38 |
| 4 | METFORMIN | 19 |
| 5 | METFORMIN ER 500 MG | 17 |
| 6 | METFORMIN ER 750 MG | 17 |
| 7 | OMEPRAZOLE MAGNESIUM | 14 |
| 8 | ADALIMUMAB | 13 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 1 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 2 | SITAGLIPTIN | 146 | 0.0020 |
| 3 | SOTAGLIFLOZIN | 1 | 0.0018 |
| 4 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 38 | 0.0018 |
| 5 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 6 | NATEGLINIDE | 2 | 0.0015 |
| 7 | CALASPARGASE PEGOL | 1 | 0.0012 |
| 8 | PANCRELIPASE | 38 | 0.0010 |
| 9 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 47 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 2 | Insulin Analog [EPC] | 19 |
| 3 | Proton Pump Inhibitor [EPC] | 16 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 5 | Loop Diuretic [EPC] | 13 |
| 6 | Corticosteroid [EPC] | 12 |
| 7 | Sulfonylurea [EPC] | 12 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 10 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Glinide [EPC] | 3 | 0.0003 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Bile Acid [EPC] | 3 | 0.0001 |
| 4 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 5 | GLP-1 Receptor Agonist [EPC] | 47 | 0.0001 |
| 6 | Sulfonylurea [EPC] | 12 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |